Global R&D Pipeline
My Favorite
Hot Targets:
CD22
Back
Total number of drugs
359
Phase II and later clinical stages
32%
Involving companies
290
Main therapeutic areas
-
Data Table
Data Chart
Select Row
Fixed Column
Download Table
Molecule Info
R&D and Market Info
ADC Info
| Drug | Drug Name En | Drug Type | Treatment Field | Mechanism of Action | Originator | Developer | Indication | Highest Development Stage | Highest Development Stage (China) | Approved Countries/Regions | Approved Time | Approved Time (China) | Special Review | ADC Type | ADC Linker | ADC Payload | ADC DAR | Drug Name | Antibody Type | ADC Linking Site | Operation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Insulin human(Eli Lilly & Co.) | Insulin human(Eli Lilly & Co.) | 1982-10-28 | 2022-08-04 | - | - | - | - | Insulin human(Eli Lilly & Co.) | - | - | detail > | ||||||||||
| Insulin aspart/insulin protamine aspart(Novo Nordisk) | Insulin aspart/insulin protamine aspart(Novo Nordisk) | 2000-08-01 | - | - | - | - | - | Insulin aspart/insulin protamine aspart(Novo Nordisk) | - | - | detail > | ||||||||||
| Insulin glargine (Sanofi) | Insulin glargine (Sanofi) | 2000-04-20 | 2003-11-07 | - | - | - | - | Insulin glargine (Sanofi) | - | - | detail > | ||||||||||
| Insulin aspart | Insulin aspart | 1999-09-07 | 2004-10-01 | - | - | - | - | Insulin aspart | - | - | detail > | ||||||||||
| Isophane Insulin | Isophane Insulin | 1997-01-01 | 1997-01-01 | - | - | - | - | Isophane Insulin | - | - | detail > | ||||||||||
| Insulin lispro | Insulin lispro | 1996-04-30 | 2000-04-26 | - | - | - | - | Insulin lispro | - | - | detail > | ||||||||||
| Chromic Chloride | Chromic Chloride | 1986-06-26 | - | - | - | - | - | Chromic Chloride | - | - | detail > | ||||||||||
| Insulin human (rDNA origin, Novo Nordisk) | Insulin human (rDNA origin, Novo Nordisk) | 1983-08-30 | 1999-07-28 | - | - | - | - | Insulin human (rDNA origin, Novo Nordisk) | - | - | detail > | ||||||||||
| Basal Insulin Fc(Eli Lilly & Co.) | Basal Insulin Fc(Eli Lilly & Co.) | - | - | - | - | - | - | Basal Insulin Fc(Eli Lilly & Co.) | - | - | detail > | ||||||||||
| Mixed Protamine Human Insulin(30R) (BIOTON) | Mixed Protamine Human Insulin(30R) (BIOTON) | - | - | - | - | - | - | Mixed Protamine Human Insulin(30R) (BIOTON) | - | - | detail > |
Total 359 data
1
2
3
4
5
6
...
35
36
